OptimizeRx raises 2025 revenue guidance to $104M-$108M as contracted revenue climbs 30%
Source: SeekingAlpha
2025-08-08 15:27:18 ET
More on OptimizeRx
- OptimizeRx Corporation (OPRX) Q2 2025 Earnings Call Transcript
- OptimizeRx: Stock Could Rise As Profitability Is Achieved
- OptimizeRx Corporation (OPRX) Q1 2025 Earnings Call Transcript
- Simulmedia & OptimizeRx partner to bring Micro-Neighborhood® targeting to TV & streaming
- OptimizeRx raises 2025 revenue guidance to $101M–$106M as subscription transition gains traction
Read the full article on Seeking Alpha
For further details see:
OptimizeRx raises 2025 revenue guidance to $104M-$108M as contracted revenue climbs 30%
OptimizeRx Corporation
NASDAQ: OPRX
OPRX Trading
0.65% G/L:
$6.15 Last:
311,923 Volume:
$6.01 Open:
OPRX Latest News
March 05, 2026 05:04:30 pm
UPDATE - OptimizeRx Reports Strong Fourth Quarter and Full Year 2025 Financial Results
March 05, 2026 04:01:00 pm
OptimizeRx Reports Strong Fourth Quarter and Full Year 2025 Financial Results
OPRX Stock Data
$189,855,041
17,596,775
3.29%
31
N/A
Healthcare Providers & Services
Healthcare
US
Waltham
